SCHEMBL3222525

SCHEMBL3222525

O=C(Nc1ccc(F)cc1)c1cc(Nc2ccc(Cl)cc2)ncn1

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.73
ERBB3 P21860 4/20 0.73
SMN1; SMN2 Q16637 3/20 0.51
RAB9A P51151 2/20 0.51
KMT2A Q03164 2/20 0.51
LMNA P02545 1/20 0.51
S1PR1 P21453 4/20 0.51
KMO O15229 1/20 0.50
LCK P06239 2/20 0.49
P2RX1 P51575 1/20 0.49
NPC1 O15118 1/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
SCN9A Q15858 1/20 0.45
TNNI3K Q59H18 1/20 0.45
MEN1 O00255 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3222813 0.95 EGFR (0.64) EGFRERBB3SMN1; SMN2RAB9AKMT2A
SCHEMBL3221284 0.90 S1PR1 (0.63) EGFRERBB3SMN1; SMN2RAB9AS1PR1
SCHEMBL3228067 0.90 EGFR (0.58) EGFRERBB3RAB9AKMT2AS1PR1
SCHEMBL13456856 0.88 EGFR (0.57) EGFRERBB3SMN1; SMN2RAB9AKMT2A
SCHEMBL3225967 0.88 EGFR (0.57) EGFRERBB3SMN1; SMN2RAB9AS1PR1
SCHEMBL3229185 0.88 EGFR (0.57) EGFRERBB3SMN1; SMN2RAB9AKMT2A
SCHEMBL3227055 0.88 S1PR1 (0.58) EGFRERBB3SMN1; SMN2RAB9AKMT2A
SCHEMBL3221150 0.88 S1PR1 (0.58) EGFRERBB3SMN1; SMN2RAB9AKMT2A
SCHEMBL3231547 0.88 EGFR (0.60) EGFRERBB3KMT2AS1PR1KMO
SCHEMBL3225361 0.87 EGFR (0.62) EGFRERBB3SMN1; SMN2RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010020432-A8 COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY BIOMARIN IGA LIMITED (BS) 2010-03-11 WO claimed
WO-2010020432-A2 COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY SUMMIT CORPORATION PLC (GB) 2010-02-25 WO claimed
WO-2010020432-A8 COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY BIOMARIN IGA LIMITED (BS) 2010-03-11 WO disclosed
WO-2010020432-A8 COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY BIOMARIN IGA LIMITED (BS) 2010-03-11 WO disclosed
WO-2010020432-A2 COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY SUMMIT CORPORATION PLC (GB) 2010-02-25 WO disclosed
WO-2010020432-A2 COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY SUMMIT CORPORATION PLC (GB) 2010-02-25 WO disclosed